Source link : https://newshealth.biz/health-news/trastuzumab-deruxtecan-scores-two-wins-in-her2-positive-early-breast-cancer/
(MedPage Today) — BERLIN — The antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) delivered impressive results in different HER2-positive early-stage breast cancer settings in back-to-back randomized clinical trials. In… Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118025 Author : Publish date : 2025-10-19 21:42:00 Copyright for syndicated content belongs to the linked Source.
The post Trastuzumab Deruxtecan Scores Two Wins in HER2-Positive Early Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-19 21:42:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8